Life Science

New biopharmaceutical production facility NGM, Luterbach

The planning for New Generation Manufacturing(NGM) was initiated in May 2015. Biogen put Jacobs, an international engineering firm from the USA, in charge of realization as full-service contractor. Burckhardt+Partner, acting as a sub-planner for Jacobs, is responsible for coordinating the administration building's approval procedure, planning and realization, as well as providing advice on matters regarding Swiss norms and standards. 

After the land had been purchased and the zoning procedure completed by the end of 2015, the canton of Solothurn issued the building permit in February 2016. Since then, construction has been pressing ahead at full steam, with the goal of handing over the entire facility to the owners by 2018. 

Two production buildings (BMC 1 and 2) with adjoining warehouse, laboratory and offices are being built on this site, which is approximately 200,000m² in size. The administration building is at the head of the production facility. A central utility building (CUB) and smaller buildings (sprinkler control center, emergency power supply) round off the installation. 

The facility has a modular structure. Production takes place in manufacturing cells (BMC). Here, Biogen's latest concepts pertaining to fed-batch culture technology and protein purification are combined to enable large-scale production of biopharmaceuticals. 

Biogen International GmbH, Zug

Period of time
2015 – 2018

55,5 Mio. CHF

Architecture, general planning